论文部分内容阅读
肝腺瘤病是一种独立的临床疾病,1985年Flejou等描述了其与肝腺瘤鉴别的主要标准:多发的肝腺瘤(10个以上),与服用类固醇无关,男女均可受累,血清碱性磷酸酶(AKP)和γ-谷氨酰转氨酶(GTP)水平异常增高,且常发生在其他方面正常的肝脏和没有糖原贮积病的病人中。该病的病因和自然病史尚不清楚,其自发性出血和恶变的倾向也有争议,也未见有特征性的影像学表现的报道。作者通过回顾1981～1998年间的15例肝腺瘤病,联系临
Hepatic adenomatosis is an independent clinical disease. In 1985, Flejou et al described the main criteria for distinguishing it from hepatic adenomas: multiple hepatic adenomas (more than 10), regardless of taking steroids, men and women can be involved, serum Alkaline phosphatase (AKP) and gamma-glutamyl transaminase (GTP) levels are abnormally elevated and often occur in otherwise normal livers and patients without glycogen storage disorders. The etiology and natural history of the disease are still unclear. The tendency of spontaneous bleeding and malignant transformation is also controversial, and no characteristic imaging findings have been reported. The author reviewed 15 cases of hepatic adenomatosis between 1981 and 1998.